The supplementary GM-CSF to neoadjuvant gemicitabine-cisplatin systemic chemotherapy plus PD-L1 blockade decrease local tumor recurrence of urothelial carcinoma after surgery via suppression of MDSCs in blood and tumor microevironment

• M. Miyake,
• S. Hori,
• N. Nishimura,
• T. Owari,
• Y. Itami,
• Y. Nakai,
• N. Tanaka,
• K. Fujimoto

Affiliations

M. Miyake

S. Hori

N. Nishimura

T. Owari

Y. Itami

Y. Nakai

N. Tanaka

K. Fujimoto